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Introduction 
Objective 
•Synthesize the self-assembling SA-K6L9-AS 
sequences 
•Use MSN to “gift wrap” the peptide sequences 
•Treat B16F10, GL26 and NSC cells with P-MSN,      
R-MSN, Tween P-MSN and Tween R-MSN
•Introduce a gate keeping system 
•Perform MTT AssayCell Lines 
• The Kansas Louis Stokes Alliance for Minority 
Participation
• Developing Scholar Program at Kansas State  
• Department of Chemistry, Kansas State University
MTT Assay
Acknowledgments 
•According to World Health Organization in 2018, 
nearly 9.6 million people worldwide are estimated to 
die from cancer. 
•Although different kinds of cancer treatments exist, 
the research communities are continuously 
developing new ways of delivering anti-cancer 
treatments to ultimately decrease the side effects and 
increase the effectiveness of the anti-cancer drugs. 
•In our lab, SA-K6L9-AS is enclosed in MSNs using 
peptide loaded  MSN  (P-MSNs) Synthesis. 
•We then used a gatekeeper system to keep the cargo 
inside the MSNs and obtain the maximal loading 
capacity.
The center of this project is to increase the maximal 
loading efficacy of the therapeutic peptide using 
Tween-based MSN and a gatekeeper. This strategy 
will prevent the drug from leaking from the MSN 
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NSC                                             B16F10
TEM Images of P-MSNs and Tween P-MSNs
Data analyzed with Graphpad Prism 5. Non-linear fit, exponetial one 
phase decay/ *Linear fit
Future Work
•Solid Phase Peptide 
Synthesis
•MSN Synthesis 
•Iron Oxide Nanoparticle Synthesis
•Lipid Bilayer Synthesis 
Methods
MTT Assay
P-MSNs Tween P-MSNs
